CGEN vs ZURA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 24, 2026

CGEN

39.5
AI Score
VS
ZURA Wins

ZURA

48.0
AI Score

Investment Advisor Scores

CGEN

40score
Recommendation
SELL

ZURA

48score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CGEN ZURA Winner
Net Income 35.34M -50.53M CGEN
Operating Income 31.33M -54.82M CGEN
ROE 34.4% -49.8% CGEN
ROA 22.6% -23.7% CGEN
Total Assets 156.57M 213.40M ZURA
Cash 90.60M 205.13M ZURA
Current Ratio 6.56 12.90 ZURA
Free Cash Flow 31.33M -39,861 CGEN

Relative Price Performance (Last 90 Days)

CGEN 1M: +11.8% · 3M: +0.2% ZURA 1M: +10.6% · 3M: +31.8%

Current Technical Phase

CGEN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 62

RSI (14): 62.0 · Price: $2.62

ZURA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (13.3% over 20 days), RSI 58

RSI (14): 57.8 · Price: $5.85

Fundamentals Snapshot

Metric CGEN ZURA
Market Cap
Forward P/E -7.1 -9.9
Trailing P/E 7.0
Revenue (TTM)
Revenue Growth 1.1% 0.0%
Gross Margin 0.9%
Operating Margin -3.4% 0.0%
EPS 0.38 -1.12
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ZURA is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.